Global Losartan Market is Poised to Grow at a CAGR of 7.81% during the Forecast Period of 2022-2031

Global losartan market was valued at USD4.73 billion in 2022 and is expected to grow at a formidable rate of 7.81% during the forecast period. The global losartan market is driven by the growing prevalence of hypertension, stroke and diabetic nephropathy across the world. Losartan is a medication that is used to treat high blood pressure. Furthermore, losartan is widely used in slowing down long-term kidney damage due to type II diabetes which is further expected to propel the market growth through 2026. The sudden outbreak and spread of the COVID-19 pandemic has resulted in the loss of jobs for many people due to which the level of anxiety and hypertension has increased among the people. This has, in turn, increased the demand for losartan, thereby fueling the market growth during the forecast period. Many major biotechnology and pharmaceutical companies are working on manufacturing in-house losartan tablets which are expected to create lucrative opportunities for the market growth over the next few years.

Download Sample of This Strategic Report: https://www.sdki.us/sample-request-111896

The global losartan market is segmented based on source, form, strength, distribution channel, application, end-user, company and region. Based on source, the market can be split into contract manufacturing organizations and in-house. Among these, the in-house segment is expected to witness the fastest growth due to increased preference for in-house manufacturing by key market players as the company can have full control over the quality and the quantity of the products. Based on form, the market can be fragmented into tablets and powder. Here, the tablet segment is dominating the market with a market share of nearly 87% and is expected to maintain its position in the forecast years as well. Based on distribution channel, the market can be segmented into online and offline. The offline channel is expected to dominate the market due to surging consumer preference for purchasing medicines from a pharmacy or drug store. The online segment is also expected to register significant growth over the next few years.

Regionally, the global losartan market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate in the overall losartan market owing to the well-established healthcare infrastructure and presence of major pharmaceutical and biotechnology giants in the region. However, Asia-Pacific is expected to witness robust growth in the market owing to the presence of a large pool of patients suffering from various life-threatening conditions in economies such as China and India.

Major players operating in the global losartan market include Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott Laboratories, Cadila Healthcare Limited, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.

Objective of the Study:
• To analyze the historical growth in the market size of the global losartan market from 2016 to 2020.
• To estimate and forecast the market size of the global losartan market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast the global losartan market based on source, form, strength, distribution channel, application, end-user, company and regional distribution.
• To identify dominant region or segment in the global losartan market.
• To identify drivers and challenges for global losartan market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global losartan market.
• To identify and analyze the profile of leading players operating in global losartan market.
• To identify key sustainable strategies adopted by market players in global losartan market.

Related Reports:

Global Losartan Market is Poised to Grow at a CAGR of 7.81% during the Forecast Period of 2022-2031
Interdental Cleansing Products Market Size in 2022 : 7.93% CAGR with Top Countries Data, Key Regions and Growth Forecast to 2031
 Disposable Syringes Market is Set to Experience a Significant Growth of 8.78% CAGR from 2022 To 2031
Global Eye Care Market Envisioned to Generate a CAGR of 6.31% from 2022-2031
India Disposable Syringes Market Size Predicted to Increase at a Positive CAGR Of 13.28% from 2022 to 2031
Global Rapid Test Kit Market is Poised to Grow at a CAGR of 8.14% during the Forecast Period of 2022-2031

Leave a Reply

Your email address will not be published. Required fields are marked *